Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Journal of Nutritional Biochemistry|September 12, 2006
Dietary isoflavones differentially induce gene expression changes in lymphocytes from postmenopausal women who form equol as compared with those who do notMihai D Niculescu, Elena A Pop, Leslie M Fischer, et al.
Menopause (New York, N.Y.)|May 1, 2008
Effects of a high daily dose of soy isoflavones on DNA damage, apoptosis, and estrogenic outcomes in healthy postmenopausal women: a phase I clinical trialElena A Pop, Leslie M Fischer, April D Coan, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 3, 2016
Characterization of Prostate Cancer in a Functional EunuchJohn J Stocking, Michael V Fiandalo, Elena A Pop, et al.
The Journal of Biological Chemistry|November 23, 2012
Melanoma antigen-A11 (MAGE-A11) enhances transcriptional activity by linking androgen receptor dimersJohn T Minges, Shifeng Su, Gail Grossman, et al.
The Prostate|August 1, 2009
Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysisSwaroop S Singh, Diana C Mehedint, O Harris Ford, et al.
Molecular and Cellular Endocrinology|October 10, 2013
Mechanism of androgen receptor corepression by CKβBP2/CRIF1, a multifunctional transcription factor coregulator expressed in prostate cancerJiann-An Tan, Suxia Bai, Gail Grossman, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 23, 2021
Differential Associations of SLCO Transporters with Prostate Cancer Aggressiveness between African Americans and European AmericansLi Tang, Qianqian Zhu, Zinian Wang, et al.
Oncotarget|March 16, 2018
Inhibition of dihydrotestosterone synthesis in prostate cancer by combined frontdoor and backdoor pathway blockadeMichael V Fiandalo, John J Stocking, Elena A Pop, et al.
Molecular Endocrinology (Baltimore, Md.)|March 30, 2012
RhoA as a mediator of clinically relevant androgen action in prostate cancer cellsLucy J Schmidt, Kelly Duncan, Neelu Yadav, et al.
Prostate Cancer|September 11, 2015
Thioredoxin 1 in Prostate Tissue Is Associated with Gleason Score, Erythrocyte Antioxidant Enzyme Activity, and Dietary AntioxidantsTerrence M Vance, Gissou Azabdaftari, Elena A Pop, et al.
Pageof 2